BRAF-mutated metastatic Melanoma: First Results on long-term Efficacy of targeted Therapies

被引：1
|
作者：
Hermann, R. M. [1 ]
Christiansen, H. [2 ]
机构：
[1] Zentrum Strahlentherapie & Radioonkol, Mozartstr 30, D-26655 Westerstede, Germany
[2] Hannover Med Sch, Klin Strahlentherapie & Spezielle Onkol, Hannover, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷 / 10期
关键词：
SURVIVAL; IPILIMUMAB;
D O I：
10.1007/s00066-019-01504-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：940 / 942
页数：3
相关论文
共 50 条
  • [1] BRAF-mutierte metastasierte Melanome: Erste Daten zur langfristigen Wirksamkeit zielgerichteter TherapienBRAF-mutated metastatic melanoma: first results on long-term efficacy of targeted therapies
    R. M. Hermann
    H. Christiansen
    Strahlentherapie und Onkologie, 2019, 195 : 940 - 942
  • [2] The Development of Vemurafenib for BRAF-mutated, Metastatic Melanoma
    Borellini, F.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S74 - S74
  • [3] Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
    Spagnolo, Francesco
    Ghiorzo, Paola
    Queirolo, Paola
    ONCOTARGET, 2014, 5 (21) : 10206 - 10221
  • [4] Recent advances in molecular targeted therapy for unresectable and metastatic BRAF-mutated melanoma
    Kiniwa, Yukiko
    Okuyama, Ryuhei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 315 - 320
  • [5] Long-term outcomes of advanced BRAF-mutated melanoma patients and complete or partial response
    Chatziioannou, E.
    Sinnberg, T.
    Leiter-Stoeppke, U.
    Flatz, L.
    Amaral, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 75 - 76
  • [6] The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
    Kim, Alex
    Cohen, Mark S.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 907 - 916
  • [7] Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma
    Kim, Hee Kyung
    Lee, Sunyoung
    Kim, Kyung
    Heo, Mi Hwa
    Lee, Hansang
    Cho, Jinhyun
    Kim, Nayoung K. D.
    Park, Woongyang
    Lee, Su Jin
    Kim, Jung Han
    Jang, Kee-Taek
    Choi, Sang-Hee
    Lee, Jeeyun
    TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 557 - 564
  • [8] Targeted Treatment of Patients with BRAF-mutated metastatic papillary Thyroid Cancer and malignant Melanoma
    Bender-Saebelkampf, S.
    Horbruegger, M.
    Tueting, T.
    Alter, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 70 - 71
  • [9] Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study
    Luke, Jason J.
    Ghate, Sameer R.
    Kish, Jonathan
    Lee, Choo Hyung
    McAllister, Lindsay
    Mehta, Sonam
    Ndife, Briana
    Feinberg, Bruce A.
    FUTURE ONCOLOGY, 2019, 15 (25) : 2933 - 2942
  • [10] Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma
    Queirolo, Paola
    Picasso, Virginia
    Spagnolo, Francesco
    CANCER TREATMENT REVIEWS, 2015, 41 (06) : 519 - 526
12345